Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.06
-0.02 (-1.85%)
At close: Jun 02, 2025, 2:17 PM
-1.85% (1D)
| Bid | 1.05 |
| Market Cap | 42.96M |
| Revenue (ttm) | 14.97M |
| Net Income (ttm) | -65.24M |
| EPS (ttm) | -1.64 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | -0.8 |
| Analyst | Buy |
| Ask | 1.08 |
| Volume | 24,694 |
| Avg. Volume (20D) | 34,576 |
| Open | 1.01 |
| Previous Close | 1.08 |
| Day's Range | 0.97 - 1.07 |
| 52-Week Range | 0.64 - 2.14 |
| Beta | -0.79 |
About BRNS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BRNS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BRNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+10.45%
Barinthus Biotherapeutics shares are trading highe...
Unlock content with
Pro Subscription
2 months ago · accessnewswire.com
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bill Enright, CEO and Gemma Brown, CFO of Barinthus Biotherapeutics plc, will be presenting at this year's Investor Summit Virtual on March 11th. About...